Medical equipment manufacturer Terumo's finances are decent, and its stock price
surged due to a stock split and expectations of strong performance.
2024/03/05
クリスのレポート
自己資本率69.3%、流動比率2.60、キャッシュフローは自己株式取得、配当金、長期借入の返済で全体がマイナス。財務的にはそこそこだがキャッシュフロー全体でマイナスなところが気になる。Bingによると、2024年３月期の業績予想が堅調なこと、2024年4月1日を基準日として株式分割するとこで株価が1000円程度上がっている。
Chris's report
Equity ratio of 69.3%, current ratio of 2.60, cash flow overall is negative due to the repurchase of treasury stock, dividend payments, and repayment of long-term debt. Financially, it's decent, but the overall negative cash flow is a concern. According to Bing, the stock price has increased by about 1000 yen due to the firm performance forecast for the fiscal year ending March 2024 and a stock split scheduled for April 1, 2024, as the record date.
株アプリで見たら株価が急騰している。なぜなんだろう？
Insight
I saw on a stock app that the stock price is soaring. I wonder why?
ミナの判断
財務的にはそこそこで売上も堅調な医療機器メーカー。好業績が株価にすで織り込まれている可能性があるため、すぐに購入を検討するような銘柄ではないと判断する。
Mina's judgment
A medical equipment manufacturer with decent finances and solid sales. It is judged not to be a stock to consider buying immediately, as the good performance may already be factored into the stock price.
